戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  expression of a betaarr1 C-terminal-derived peptide fragment.
2 hic secreted APPalpha (sAPPalpha) and the P3 peptide fragment.
3 d trypsin enzymes on NAA-NH(2) into the heme-peptide fragment.
4 ation may prevent the formation of cytotoxic peptide fragments.
5 nize the organismal origin of unknown DNA or peptide fragments.
6 in the hydrolysis of polypeptides into small peptide fragments.
7 ion NMR, and concomitant appearance of small peptide fragments.
8 ntimicrobial defense by clustering in active peptide fragments.
9 e of proIAPP in detail by analyzing a set of peptide fragments.
10 ent for intact proteins rather than degraded peptide fragments.
11 ire processing of native proteins into short peptide fragments.
12 hat is based on the coupling of glycopeptide/peptide fragments.
13 ro, staphopain B degraded LL-37 into shorter peptide fragments.
14 hod for the total synthesis of proteins from peptide fragments.
15 d comparative mass spectrometric analysis of peptide fragments.
16  leading to the formation of Abeta and Abeta peptide fragments.
17 ave studied the characteristics of these two peptide fragments.
18 erform native chemical ligation (NCL) of two peptide fragments.
19 ide bond formation between a large number of peptide fragments.
20 uently requires proteolysis of proteins into peptide fragments.
21 as obtained through N-terminal sequencing of peptide fragments.
22 ell as circulating N-terminal and C-terminal peptide fragments.
23 '-phosphorylated pentanucleotides containing peptide fragments.
24 ased upon single-stranded DNA scaffolding of peptide fragments.
25 only a few structures of oligomers formed by peptide fragments.
26 e semisynthesis via the chemical ligation of peptide fragments.
27 ti-apoptotic N1 and the scrapie-resistant C1 peptide fragments.
28 hat generate the pathogenic or nonpathogenic peptide fragments.
29  where it cleaves food proteins into smaller peptide fragments.
30 bn-N) and the TRAP (tyrosine-rich amelogenin peptide) fragments.
31                  We have used the activation peptide fragment 1.2 (F12), a ligand for anion-binding e
32                The molecular conformation of peptide fragment 105-115 of transthyretin, TTR(105-115),
33                                          One peptide fragment (19 amino acids) spans IGF-I residues 7
34     Synthesis and coupling of the individual peptide fragments [34 + 35 --> 51] followed by macrocycl
35 Preabsorption of the antiserum with metastin peptide fragment (45-54)-NH2 (1 microg/ml) resulted in n
36 um directed against the synthetic C-terminal peptide fragment (47-73), irBC was detected in the mouse
37 sing amino acid sequences derived from Csp24 peptide fragments, a full-length cDNA was cloned and sho
38 perature phase diagram for the amyloidogenic peptide fragment Abeta(16-22) Our results reveal that th
39 d chromatography fraction revealed two alpha-peptide fragments (alpha128-alpha139) and a heme moiety
40 ing of complex fragments, including a 20-mer peptide fragment analog of Exendin(9-39) on solid suppor
41                                              Peptide fragment analysis of the diagnostic peak in amni
42 ng an efficient solid phase synthesis of the peptide fragment and an effective chemoenzymatic attachm
43 esulted in the cleavage of the MB containing peptide fragment and caused a decrease in electrical sig
44 ucture of Naa50p bound to a native substrate peptide fragment and CoA.
45 d PKC-stimulated phosphorylation of the same peptide fragments and comigration of PKC-stimulated phos
46              We have identified Mtb-specific peptide fragments and developed a method to rapidly quan
47 corresponding to the carbohydrate-containing peptide fragments and large and small trypsin fragments
48 with MALDI-TOF mass spectrometry analysis of peptide fragments and peptide microsequencing, indicates
49 of the MHC class I heavy chain, an antigenic peptide fragment, and beta2-microglobulin (beta2m).
50 ences, native chemical ligation from smaller peptide fragments, and a high-throughput bacterial expre
51 sequence patterns, distinct from non-binding peptide fragments, and multi-millions of binding and non
52 -expressed T-cell receptors (TCRs) recognize peptide fragments (antigens) of pathogens bound to major
53 h analyses typically assume that a protein's peptide fragments are observed with equal likelihood, on
54                             Such 10 purified peptide fragments are screened against sera from patient
55 -isotope tags and fragmented, and the tagged peptide fragments are separated by liquid chromatography
56 s in the fluorescence intensity of a labeled peptide fragment as well as a decrease in solution pH as
57  measuring the oxidation extent of different peptide fragments as a function of microwave power.
58                                The resulting peptide fragment assembles into fibrils promoting the fo
59  mechanisms by which beta-amyloid (Abeta), a peptide fragment believed to contribute to Alzheimer's d
60 dentify differentially abundant proteins and peptide fragments between age groups.
61 ld SPI forms large ions identified as common peptide fragments bound to either Fmoc or the surface li
62  effective in preliminary searches for C-PTH peptide fragments, but the use of high laser power limit
63 ation of surface labeled and biotin captured peptide fragments by LC/MS/MS.
64                            Here we show that peptide fragments can be exchanged by a chemoselective a
65 observations that the amino acid sequence of peptide fragments can change upon activation.
66 vealed that the CB1 C-terminal juxtamembrane peptide fragment CB1-(401-417) can directly activate the
67 nhardtii caltractin (CRC-C) and a 19 residue peptide fragment comprising the putative cdc31p-binding
68 ctional characteristics of template-directed peptide fragment condensation reactions in neutral aqueo
69 offer the promise of using this chemistry in peptide fragment condensations to produce modified pepti
70                                       Use of peptide fragments confirm that PrP(92-96) and PrP(107-11
71  receptor, while [ (125)I]IAC44 was found in peptide fragments consistent with labeling of both SBDLI
72                      These resistant Ara h 2 peptide fragments contain intact IgE-binding epitopes an
73                                         This peptide fragment contained a sequence that corresponded
74  in its amino acid sequence and that a TcSSS peptide fragment containing a sequence homologous to a b
75  and RGS16 incorporated [3H]palmitate into a peptide fragment containing Cys-98, a highly conserved c
76                 Moreover, we show that a CTD peptide fragment containing His-447, His-449, and Cys-45
77                       A 5-kDa tryptic digest peptide fragment containing six acidic residues at posit
78 o signal, whereas the enzymatically produced peptide fragment containing the above sequence showed th
79                             Finally, a short peptide fragment containing the NCX1-Met(369) cleavage s
80                            We identified six peptide fragments containing 12 phosphorylated residues
81 718 and 1831, corresponding to the unlabeled peptide fragments containing the active site Tyr411 resi
82 fibrils are built by modifying the synthetic peptide fragment corresponding to residues 105-115 of th
83 tion of vectors that drive the expression of peptide fragments corresponding to their binding domains
84 cortactin Src homology 3 (SH3) domain with a peptide fragment derived from a cDNA encoding a region o
85                   We previously discovered a peptide fragment derived from A46 termed VIPER (Viral In
86 tal surface with REDOR NMR show that, in the peptide fragment derived from the N-terminal 15 amino ac
87 ative cysteine with a succinimide group in a peptide fragment derived from thioredoxin-1 (Trx-1) obta
88 f high-resolution structures of CaM bound to peptide fragments derived from ion channels, there is no
89  are made up of multiple naturally occurring peptide fragments derived from semen.
90                                              Peptide fragments derived from the C terminus of C5a can
91                                     A set of peptide fragments derived from the headpiece were also c
92 ancing activity parallels the degradation of peptide fragments derived from the semenogelins (SEMs),
93 the Ru label, whereas binding of the cleaved peptide fragment devoid of Ru label reduced the ECL sign
94  to P37-42, OspA, GT, or six overlapping Arp peptide fragments did not.
95 L) method that enables efficient ligation of peptide fragments down to low nanomolar concentrations,
96          Cu(I) ligation by a Cys-rich domain peptide fragment drives the cooperative assembly of a po
97 measure the molecular weights of the tryptic peptide fragments (e.g., peptide mass mapping) and parti
98  rabbit antiserum raised against a synthetic peptide fragment encoding the unique C terminus revealed
99 ing the Rosetta fragment picker for accurate peptide fragment ensemble generation, the PIPER docking
100 uence patterns between intra-protein binding peptide fragments exist, they can be extracted using a d
101 the peptide mass fingerprint (MALDI-TOF) and peptide fragment fingerprinting (MALDI LIFT-TOF/TOF) spe
102                                              Peptide fragments for mass spectrometry analysis were ob
103                 A key observation was that a peptide fragment formed of the first N-terminal 15 resid
104 on these regions, we focused on an antigenic peptide fragment from a disulfide bridge-bounded region
105                               In contrast, a peptide fragment from domain C reduced the number of syn
106                         PAPf39, a 39-residue peptide fragment from human prostatic acidic phosphatase
107 anic molecule (fluorescein), a 12 amino acid peptide fragment from the C-terminus of beta-catenin, th
108                       PAPf39 is a 39-residue peptide fragment from the sequence of human prostatic ac
109                               Titration of a peptide fragment from the yeast Kar1p protein to the iso
110 xpensive methodology to generate fluorescent peptide fragments from a parent sequence with diverse ch
111 toreceptor retinoid-binding protein dose and peptide fragments from conventional experimental autoimm
112 nd multi-millions of binding and non-binding peptide fragments from currently available protein X-ray
113 tration calorimetry to investigate synthetic peptide fragments from different domains of the full-len
114                                 Biotinylated peptide fragments from labeled proteomes are captured an
115                        In semen, proteolytic peptide fragments from prostatic acid phosphatase can fo
116         However, TDP1 can only process small peptide fragments from ssDNA ends, raising the question
117                                              Peptide fragments from standard protein digests of bovin
118                      Host cells also display peptide fragments from the host's own proteins.
119 tact tetramer, and (3) release of C-terminal peptide fragments from the intact complex.
120                             Three phosphoThr peptide fragments from the kinase domain of CLV1 or BAK1
121 hr, and Tyr residues in intact proteins with peptide fragments from the same proteins.
122  peptide (2.5HIP) consisting of an insulin C-peptide fragment fused to a peptide from chromogranin A
123 proteins and/or an LC-MS analysis of tryptic peptide fragments generated after the oxidation reaction
124                                              Peptide fragments generated by collagenolysis, and the c
125 taL-crystallin was higher in the presence of peptide fragments generated from oxidized and trypsin-di
126                      MALDI MS/MS analysis of peptide fragments generated from the large-diameter core
127 , isoaspartic, and aspartic acid isoforms of peptide fragments generated using trypsin.
128 erefore been necessary, for instance, on the peptide fragment GNNQQNY7-13 of yeast prion protein Sup3
129                       Structural analysis of peptide fragments has provided useful information on the
130 l crystal structures of skeletal muscle RyR1 peptide fragments have been solved, but these cover less
131                    The intra-protein binding peptide fragments have specific and intrinsic sequence p
132 he side chain of the self-assembling amyloid peptide fragment HHQALVFFA to give ccAQLVFFA.
133 with CD and 1D NMR studies of the 21-residue peptide fragment (HP21) derived from HP36 have shown tha
134 s work, for the first time, four human C-PTH peptide fragments, hPTH(34-84), hPTH(37-84), hPTH(38-84)
135                               The four C-PTH peptide fragments identified in plasma samples from pati
136 les protein sequences from their constituent peptide fragments identified on short reads.
137 oth cell types, and amino acid sequencing of peptide fragments identified the same protein, histone H
138  antibodies against GB-generated centromeric peptide fragments identify a distinct clinical subset.
139 hat inhibit the recruitment of a coactivator peptide fragment in in vitro biochemical assays (IC(50)
140 simultaneous detection of PTHrP isoforms and peptide fragments in 30 min.
141 signature for identifying inhibitor-modified peptide fragments in complex mass spectrometry data.
142 showed that the distribution patterns of the peptide fragments in Gl-L and Gd-L were similar, but mor
143 esults suggest novel roles for ATIII-derived peptide fragments in host defense.
144 d approaches were capable of detecting C-PTH peptide fragments in human plasma at <10 pmol/L.
145 l as the presence of the individual (intact) peptide fragments in MS2 spectra.
146 , we identified over one dozen APP-generated peptide fragments in wild-type yeast (PRE1PRE2) and over
147                                      Tryptic peptides fragment in ion trap tandem mass spectrometry t
148 on program, it was observed that some cyclic peptides fragmented in unexpected ways resulting in the
149 eave chromogranin A into biologically active peptide fragments, including catestatin, which inhibits
150                    We used recombinant MMP12 peptide fragments, including its catalytic domain, CTD,
151 ry/mass spectrometry analysis on the tryptic peptide fragments indicates that the 3-fluorosialyl moie
152  reached by using only seven short synthetic peptide fragments, instead of the 155 non-overlapping 15
153 1 at multiple sites to release transmembrane peptide fragments into the aqueous solvent.
154 ecursors, presentation requires transport of peptide fragments into the ER, but the nature of the cyt
155 site-specific integration of amino acids and peptide fragments into the homodetic cyclic peptide arch
156 nt ions to probe the components of gas-phase peptide fragment ion isomers.
157 ed by a diagnostic mass shift in one or more peptide fragment ions (for example, phosphorylation).
158 s into unused spectral space where no native peptide fragment ions exist.
159 ion and quantification of twinned peaks from peptide fragment ions in MS(2) spectra.
160 aining reagents for shifting mass defects of peptide fragment ions was systematically investigated, t
161    The ASA method successfully distinguishes peptide fragment ions with and without an FIMDL group an
162 well as for facile mass spectral analysis of peptide fragment ions with increased mass defects.
163 ctra included singly protonated peptide ion, peptide fragment ions, and peaks characteristic of the s
164 dentification of these separated proteins or peptide fragments is typically achieved by mass spectrom
165                                Sequencing of peptide fragments isolated from [(3)H]CMPI-photolabeled
166 ce with the mixed GAG glycosylation of agrin peptide fragments, it was found that recombinant and in
167 e (TDP1) is a DNA repair enzyme that removes peptide fragments linked through tyrosine to the 3' end
168  type glycopeptide fraction revealed Asn-732 peptide fragments linked to the sulfoquinovose-containin
169  that exist in vertebrates, presenting small peptide fragments, lipid molecules, or small molecule me
170 ing and assembling the native structure from peptide fragments, local structures first.
171  for DnaK, examined via a short 13-mer apoMb peptide fragment matching the binding site sequence, dis
172 f spermatogenesis suggests that this laminin peptide fragment may serve as a contraceptive in male ra
173           The specific binding between short peptide fragments may provide an important driving force
174 inally, intracellular application of the MIF peptide fragment MIF-(50-65), which harbors the thiol ox
175 he biotinylated peptides and analysis of the peptide fragment mixture by nanospray liquid chromatogra
176 sis of the pepsin-induced fibrils implicates peptide fragments (named H) consisting of the 13 or 15 N
177       Furthermore, we identified several new peptide fragments (neopeptides) present in aged tendons,
178                    Application of the active peptide fragment NT8-13 produced synaptic depression tha
179 gen-associated molecular patterns, including peptide fragment of bacterial flagellin (flg22) or trans
180                   It was shown that a 45-mer peptide fragment of collagen type II with five hydroxypr
181 Using in vitro systems, we have identified a peptide fragment of gankyrin, 176LHLACDEERN185, which is
182       Previously, we have identified a small peptide fragment of IL-2 that was found to contain the e
183 reatment of MeCP2 mutant mice with an active peptide fragment of Insulin-like Growth Factor 1 (IGF-1)
184 as reinhardtii centrin for calcium and for a peptide fragment of Kar1p using CD, fluorescence, and NM
185 that the binding mode and stoichiometry of a peptide fragment of NDR (NDR(62-87)) is the same as for
186 location of PPAR-gamma is blocked by a short peptide fragment of NOC that inhibits its physical inter
187  bound to a 15 amino acid residue N-terminal peptide fragment of p85.
188                            PAP(248-286) is a peptide fragment of prostatic acid phosphatase and has b
189 I), an amyloid fibril formed from a cationic peptide fragment of prostatic acidic phosphatase (PAP),
190          Adult SJL mice injected i.p. with a peptide fragment of proteolipid protein (a candidate aut
191                                          One peptide fragment of semenogelin I, termed SG-1, was puri
192 we report the high-resolution structure of a peptide fragment of the amyloidogenic protein transthyre
193               Introduction of the C-terminal peptide fragment of the ArPIKfyve-ArPIKfyve contact site
194                          Dialysis of a small peptide fragment of the auxiliary beta4 Na(+) channel su
195                                          The peptide fragment of the channel is based on a conserved
196 f cancer marker protein Ki67 (Ki67FHA) and a peptide fragment of the hNIFK signaling protein.
197            This study indicates that a small peptide fragment of the human PEDF molecule could be eng
198                                            A peptide fragment of the I-II loop was purified from bact
199 assessed whether administration of a soluble peptide fragment of the NgR (sNgR) that binds to and blo
200 myloid fibrils formed from a self-assembling peptide fragment of the protein prostatic acid phosphata
201                                A recombinant peptide fragment of the SMRT (silencing mediator for ret
202                    NMR studies showed that a peptide fragment of the V2R C terminus containing the RG
203 d VEGF-A binding in the NRP1 b1 domain and a peptide fragment of VEGF-A was shown to bind at the same
204 haracterize separation between amyloidogenic peptide fragments of alpha-synuclein.
205  of DCs to internalize, degrade, and express peptide fragments of antigenic proteins on their surface
206 s were substantially inhibited by N-terminal peptide fragments of Anxa2 or anti-Anxa2 antibodies.
207                     CD8(+) T cells recognize peptide fragments of endogenously synthesized antigens o
208 uence curvature sensing and explores whether peptide fragments of even shorter length can function as
209 ss spectrometric analysis of the proteolytic peptide fragments of IN.
210 tagonists of NgR derived from amino-terminal peptide fragments of Nogo-66.
211 roups by those measured by Kuhlman et al. in peptide fragments of NTL9.
212 pansion, followed by exposure to overlapping peptide fragments of PE38 and an IL-2 ELISpot assay to m
213 cyte Antigen (HLA) Class I molecules bind to peptide fragments of proteins degraded inside the cell a
214 ificant reactions of the monochloramine with peptide fragments of proteins that are associated with c
215 gators have therefore preferred to work with peptide fragments of PrP, suggesting that these peptides
216 ficity of otherwise poorly active N-terminal peptide fragments of PTH by conjugating them to nanobodi
217 betic (NOD) mice, repeated administration of peptide fragments of target antigens in incomplete Freun
218  ionization mass spectrometry identified two peptide fragments of the alphaB crystallin Walker-B moti
219 posits of insoluble, fibrillar aggregates of peptide fragments of the amyloid precursor protein (APP)
220 state: the protein in 6 M urea, and unfolded peptide fragments of the protein in water.
221   Previous studies have shown that synthetic peptide fragments of the PrP sequence corresponding to r
222                                  The tryptic peptide fragments of this phosphoprotein were sequenced
223       Importantly, expression of recombinant peptide fragments of wild-type SOD1 in cultured cells al
224 the modified ubiquitin and isomeric glycated peptides (fragments of bovine serum albumin (BSA)).
225 on, expression of a dominant negative mutant peptide fragment or injection of a function-blocking ant
226  allows the controlled production of typical peptide fragments or elemental reporter ions informing a
227 gamma-chains of fibrin and the appearance of peptide fragments over time were assessed by polyacrylam
228 he CD8(+) T-cell surface interact with short peptide fragments (p) bound to MHC class I molecules (pM
229                             In addition, the peptide fragment PAMP(12-20) inhibits tumor cell-induced
230                                  Recently, a peptide fragment (PAP(248-286)) has been isolated from s
231          On uPA activation, NIR-NFP releases peptide fragments (PEG(54)-BK(NIR664)SGR-CONH(2)) that c
232   Full-length and conserved C-terminal delta peptide fragments permeabilize the plasma membranes of n
233 olyglutamine-expanded huntingtin protein and peptide fragments (polyQ-Htt).
234                         CTLs recognize short peptide fragments presented in association with MHC clas
235 udy, we provide evidence that the C-terminal peptide fragment produced by caspase cleavage inhibits t
236   Low molecular weight protamine (LMWP) is a peptide fragment produced in our laboratory from enzymat
237          These results indicate that urinary peptide fragments reflect changes in expression of intac
238 scopic and mass spectrometric studies of the peptide fragments resulting from tryptic digestion of Ka
239 nce liquid chromatographic separation of the peptide fragments resulting from tryptic digestion of re
240 and structure of microbial communities using peptide fragment sequences extracted from metagenomic se
241       Both VGF and pro-SAAS are cleaved into peptide fragments, several of which are biologically act
242 em, it is generally assumed that angiotensin peptide fragments shorter than angiotensins II and III,
243 ts on the full alphatalpha motif and its two peptide fragments show that interhelical tertiary contac
244 ons followed by MALDI-TOF MS analysis of the peptide fragments showed these 47 kDa species to be CRP
245                                A serine-rich peptide fragment spanning residues 221 to 240 was highly
246 e species include full-length SOD1 proteins, peptide fragments, stable oligomers and ubiquitinated en
247 ) NMR study of the fibrils formed by a small peptide fragment, structural details of beta(2)m fibrils
248 tive did not identify any covalently labeled peptide fragments, suggesting that the phenylazido side
249 ansfected HEK-293 cells revealed that a CFTR peptide fragment that binds AMPK (CFTR-1420-57) disrupte
250 an be used as a template to design a minimal peptide fragment that can be used as a drug against Rho-
251          A crystal structure, solved using a peptide fragment that contained residues 12 to 60, depic
252 e the solution structure of the Abeta(21-30) peptide fragment that may be relevant for understanding
253                                            A peptide fragment that spans the IQ motif of p68 strongly
254 otease digestion of the complex, generated a peptide fragment that was bound to the SG promoter.
255 ty of SagA is required and generates muramyl-peptide fragments that are sufficient to protect C. eleg
256 oach involves the digestion of proteins into peptide fragments that can be detected and sequenced wit
257 radation, inflammation and invasion liberate peptide fragments that can subsequently interact with ce
258 th or without CKI-alpha depletion identified peptide fragments that corresponded to the region locate
259 osurvival signaling or generate proapoptotic peptide fragments that help to execute the death program
260                  Consistent with this model, peptide fragments that included the membrane binding reg
261 arboxyl-terminal parathyroid hormone (C-PTH) peptide fragments that may be present at only picomolar
262 acquisition of approximately 100 overlapping peptide fragments that redundantly cover the 243-residue
263  that barnase can be split into two inactive peptide fragments, that when co-expressed can complement
264  the C-terminal acyl donor and using smaller peptide fragments, the Cys(29)-Gly(77) glycopeptide doma
265  derived from automatic Edman degradation of peptide fragments, the SmCI sequence was fully character
266   Alanine ligation was used to assemble four peptide fragments, themselves prepared by solid phase pe
267                                     The heme-peptide fragment then oxidized 2,2'-azino-bis(3-ethylben
268  are generally characterized through tryptic peptide fragments, this paper reports a method for the i
269 ies via the deactivation of the SrtA-excised peptide fragment through diketopiperazine (DKP) formatio
270 ble to effectively stabilize the problematic peptide fragment through the attachment of cleavable arg
271 omochiral products from a racemic mixture of peptide fragments through a chiroselective autocatalytic
272  acyl-enzyme intermediate linking one of the peptide fragment to a catalytic subunit of the proteasom
273  MyBP-C (cMyBP-C), we added human N-terminal peptide fragments to human and rodent skinned ventricula
274                                            A peptide fragment, UQ(1-51), encompassing residues 1 to 5
275 ex with the human receptor and a coactivator peptide fragment using x-ray crystallography at 1.9-A re
276         However, the challenging exchange of peptide fragments using a dynamic covalent peptide bond
277 d 168 h and the supernatant was screened for peptide fragments using Tandem Mass Spectrometry.
278                                      A major peptide fragment was detected at m/z 1088 by a MALDI-TOF
279  increase in the relative intensities of the peptide fragments was achieved, which led to the identif
280 ity relationship of human LL-37, a series of peptide fragments was designed.
281 aterial throughput and convergency, the five peptide fragments were assembled into the native ATAD2 b
282 ch protein digest and the number of detected peptide fragments were compared with conventional MALDI
283 the peptide bonds of BSA were hydrolyzed and peptide fragments were desorbed from the surface of gold
284                                     The same peptide fragments were formed when the lead peptide was
285                   Three distinct p21 derived peptide fragments were found to bind to DAPK; however, t
286 ll-length Gag-p24 protein, and the resulting peptide fragments were identified by mass spectrometry.
287 ng MALDI-TOF MS, and 102 out of 153 possible peptide fragments were identified giving a sequence cove
288 digested with chymotrypsin, and the modified peptide fragments were isolated and characterized as 6-h
289                                        C-PTH peptide fragments were isolated from plasma samples by i
290 ed caspase-3 in vitro, 13- and 17-kDa capsid peptide fragments were observed and were predicted by al
291 th trypsin and endoproteinase Asp-N, and the peptide fragments were purified by high performance liqu
292 le GFAP- and MBP-immunoreactive proteins and peptide fragments were seen, and many of them were also
293                              Nonglycosylated peptide fragments were susceptible to complete Pronase d
294 istinct proteasomal degradation patterns and peptide fragments were unique to either mature DC or act
295                                     A longer peptide fragment which contains the first and second hel
296 ) is a naturally occurring 40- or 42-residue peptide fragment with a primary role in Alzheimer's dise
297 B), specifically and rapidly hydrolyzes stem peptide fragments with a free N-terminus.
298 omic sequence collections revealed groups of peptide fragments with a relatively high abundance and n
299               N-terminally formylated signal peptide fragments with variable sequence and length acti
300 driven dissociation because glycan-retaining peptide fragments would not be required for localization

 
Page Top